Overview

Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning

Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
This study will be performed at clinical sites that have administered CardioGen-82® to patients from January to July 2011. The patients enrolled(i.e., "target date patients") will be all those who were dosed at the end of use of the CardioGen-82® generators on the last day of generator use from the generator that was used immediately prior to the recalled generator (i.e., "target date generators"). These are not patients who received drug eluted from the recalled generator. Of these patients, it is planned that 100 patients will be entered in this trial.
Details
Lead Sponsor:
Bracco Diagnostics, Inc